DEXCEL-PHARMA LABORATORIES LIMITED
Get an alert when DEXCEL-PHARMA LABORATORIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£4.4m
highest in 3 filed years
Net assets
£33m
highest in 3 filed years
Employees
26
highest in 3 filed years
Profit before tax
£4m
Period ending 2025-12-31
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-06-30 | 2024-06-30 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £27,584,426 | £21,547,541 | £39,086,522 | — | |
| Operating profit | -£3,625,179 | £1,215,756 | £3,816,730 | — | |
| Profit before tax | -£3,624,958 | £1,308,801 | £4,007,637 | — | |
| Net profit | -£4,146,233 | £842,931 | £2,809,866 | — | |
| Cash | £3,260,073 | £2,468,266 | £4,389,906 | — | |
| Total assets less current liabilities | £22,641,437 | £29,846,668 | £32,653,918 | — | |
| Net assets | £22,641,437 | £29,733,307 | £32,543,173 | — | |
| Equity | £22,641,437 | £29,733,307 | £32,543,173 | — | |
| Average employees | 21 | 22 | 26 | — | |
| Wages | £1,822,359 | £1,427,199 | £2,597,220 | — | |
| Directors' remuneration | £173,834 | £229,206 | £306,528 | — | |
| Directors' pension contributions | £12,117 | £10,279 | £49,688 | — | |
| Highest paid director | £173,834 | £200,811 | £230,425 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. Year-on-year comparison hidden: this filing covers about 18 months versus 12 months prior. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-06-30 | 2024-06-30 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | -13.1% | 5.6% | 9.8% | |
| Net margin | -15.0% | 3.9% | 7.2% | |
| Return on capital employed | -16.0% | 4.1% | 11.7% | |
| Gearing (liabilities / total assets) | 22.2% | 17.5% | 9.3% | |
| Current ratio | 2.54x | 2.91x | 6.53x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- MHA
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“the directors consider the Company and Group have the ability to continue as a going concern for the next 12 months and therefore these financial statements have been prepared on a going concern basis. No material uncertainty in relation to going concern has been identified.”
Group structure
- DEXCEL-PHARMA LABORATORIES LIMITED · parent
- Dexcel-Pharma Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KONSTANTINOU, Anastasis | Director | 2014-06-24 | Jul 1984 | Cypriot |
| OTUK, Enis | Director | 2026-09-01 | Jul 1975 | British |
| SEELENFREUND, Yigal | Director | 2022-05-23 | Aug 1967 | Israeli |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FLIPPANCE, Brian John | Secretary | 2011-09-26 | 2013-12-05 |
| GRIGG, Terry Kenneth | Secretary | 2013-12-05 | 2022-05-23 |
| WHATSIZE, Sarah | Secretary | 2006-12-19 | 2010-11-22 |
| CORPORATE SECRETARIES LIMITED | Corporate Secretary | 2006-12-19 | 2006-12-19 |
| AVRAHAM, Dov | Director | 2010-11-01 | 2014-06-24 |
| CARMELI, Liel | Director | 2006-12-19 | 2010-11-01 |
| GRIGG, Terry | Director | 2006-12-19 | 2022-05-23 |
| KAPPLER, Michael Roy | Director | 2006-12-19 | 2010-05-10 |
| RIDSDALE, Andrew John | Director | 2022-05-23 | 2026-08-31 |
| SEELENFREUND, Ygal | Director | 2006-12-19 | 2008-10-27 |
| WHATSIZE, Sarah | Director | 2006-12-19 | 2010-11-22 |
| CORPORATE DIRECTORS LIMITED | Corporate Director | 2006-12-19 | 2006-12-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Dan Oren | Individual | Shares 25–50% | 2026-02-26 | Active |
| Dexcel Pt Israel Ltd | Corporate entity | Shares 75–100% | 2016-12-19 | Ceased 2026-02-26 |
Filing timeline
Last 20 of 82 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-30 | AA | accounts | Accounts with accounts type group | |
| 2026-09-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-09-01 | TM01 | officers | Termination director company with name termination date | |
| 2026-09-01 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-26 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-02-26 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-11-13 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-11-05 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-09-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-19 | AA01 | accounts | Change account reference date company | |
| 2025-03-28 | AA | accounts | Accounts with accounts type group | |
| 2024-09-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-28 | AA | accounts | Accounts with accounts type group | |
| 2023-09-14 | AA01 | accounts | Change account reference date company previous extended | |
| 2023-09-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-30 | AA | accounts | Accounts with accounts type group | |
| 2022-05-25 | AP01 | officers | Appoint person director company with name date | |
| 2022-05-24 | AP01 | officers | Appoint person director company with name date | |
| 2022-05-24 | TM02 | officers | Termination secretary company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.